Literature DB >> 11440838

Photocytotoxicity of lipofuscin in human retinal pigment epithelial cells.

S Davies1, M H Elliott, E Floor, T G Truscott, M Zareba, T Sarna, F A Shamsi, M E Boulton.   

Abstract

Lipofuscin accumulates with age in a variety of highly metabolically active cells, including the retinal pigment epithelium (RPE) of the eye, where its photoreactivity has the potential for cellular damage. The aim of this study was to assess the phototoxic potential of lipofuscin in the retina. RPE cell cultures were fed isolated lipofuscin granules and maintained in basal medium for 7 d. Control cells lacking granules were cultured in an identical manner. Cultures were either maintained in the dark or exposed to visible light (2.8 mWcm2) at 37 degrees C for up to 48 h. Cells were subsequently assessed for alterations in cell morphology, cell viability, lysosomal stability, lipid peroxidation, and protein oxidation. Exposure of lipofuscin-fed cells to short wavelength visible light (390-550 nm) caused lipid peroxidation (increased levels of malondialdehyde and 4-hydroxy-nonenal), protein oxidation (protein carbonyl formation), loss of lysosomal integrity, cytoplasmic vacuolation, and membrane blebbing culminating in cell death. This effect was wavelength-dependent because light exposure at 550 to 800 nm had no adverse effect on lipofuscin-loaded cells. These results confirm the photoxicity of lipofuscin in a cellular system and implicate it in cell dysfunction such as occurs in ageing and retinal diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440838     DOI: 10.1016/s0891-5849(01)00582-2

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  49 in total

1.  Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damage.

Authors:  Sven Erik G Nilsson; Staffan P Sundelin; Ulf Wihlmark; Ulf T Brunk
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

2.  Spectroscopic and morphological studies of human retinal lipofuscin granules.

Authors:  Nicole M Haralampus-Grynaviski; Laura E Lamb; Christine M R Clancy; Christine Skumatz; Janice M Burke; Tadeusz Sarna; John D Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-28       Impact factor: 11.205

Review 3.  Ageing of the retinal pigment epithelium: implications for transplantation.

Authors:  Mike Boulton; Malgorzata Róanowska; Tim Wess
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-09       Impact factor: 3.117

Review 4.  Keypathophysiologic pathways in age-related macular disease.

Authors:  Felix Roth; Almut Bindewald; Frank G Holz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-08-10       Impact factor: 3.117

5.  [RPE transplantation: the challenges and the future].

Authors:  M E Boulton
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

Review 6.  Retinal light toxicity.

Authors:  P N Youssef; N Sheibani; D M Albert
Journal:  Eye (Lond)       Date:  2010-10-29       Impact factor: 3.775

Review 7.  Studying melanin and lipofuscin in RPE cell culture models.

Authors:  Michael E Boulton
Journal:  Exp Eye Res       Date:  2014-09       Impact factor: 3.467

8.  The proteasome: a target of oxidative damage in cultured human retina pigment epithelial cells.

Authors:  Xinyu Zhang; Jilin Zhou; Alexandre F Fernandes; Janet R Sparrow; Paulo Pereira; Allen Taylor; Fu Shang
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-11       Impact factor: 4.799

9.  Sublethal photic stress and the motility of RPE phagosomes and melanosomes.

Authors:  Janice M Burke; Mariusz Zareba
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-13       Impact factor: 4.799

10.  Subcellular distribution and activity of mechanistic target of rapamycin in aged retinal pigment epithelium.

Authors:  Bo Yu; Pei Xu; Zhenyang Zhao; Jiyang Cai; Paul Sternberg; Yan Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.